mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.02 |